evidence: Renal function parameters were similar between study arms although a small increase in NGAL was detected among TDF-treated patients.
intervention: Tenofovir/emtricitabine (TDF/FTC)
comparator: Abacavir/lamivudine (ABC/3TC) 
outcome: Lumbar spine bone mass density at weeks 24 and 48